Nikhil Aneja - 29 Jan 2026 Form 3 Insider Report for Aligos Therapeutics, Inc. (ALGS)

Role: Principal Accounting Officer
Signature: /s/ Lesley Ann Calhoun, as attorney-in fact for Nikhil Aneja
Issuer symbol: ALGS
Transactions as of: 29 Jan 2026
Net transactions value: $0
Form type: 3
Filing time: 19 Feb 2026, 17:54:15 UTC
Next filing: 11 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Aneja Nikhil	Principal Accounting Officer	C/O ALIGOS THERAPEUTICS, INC., 1 CORPORATE DRIVE, 2ND FLOOR, SOUTH SAN FRANCISCO	/s/ Lesley Ann Calhoun, as attorney-in fact for Nikhil Aneja	19 Feb 2026	0002112438

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	ALGS	Stock Option (Right to Buy)							29 Jan 2026	Common Stock	3,800	$16.00	Direct	F1
holding	ALGS	Stock Option (Right to Buy)							29 Jan 2026	Common Stock	2,640	$11.74	Direct	F2
holding	ALGS	Stock Option (Right to Buy)							29 Jan 2026	Common Stock	7,155	$16.87	Direct	F3
holding	ALGS	Stock Option (Right to Buy)							29 Jan 2026	Common Stock	3,600	$8.68	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	25% of the total number of shares vest in one year and 1/36th of the remaining total number of shares vest in thirty-six (36) successive and equal monthly installments measured one year following February 13, 2024 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.
F2	1/48th of the total number of shares vest in forty-eight (48) successive and equal monthly installments measured from September 4, 2024 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.
F3	1/48th of the total number of shares vest in forty-eight (48) successive and equal monthly installments measured from February 28, 2025 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.
F4	1/48th of the total number of shares vest in forty-eight (48) successive and equal monthly installments measured from July 16, 2025 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.

Remarks:

Exhibit 24 - Power of Attorney